Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinyu Bi

Showing results (31-40 of 132) with videos related to

Pageof 14
Sort By:
Liver Cancer|February 20, 2020
Chinese Expert Consensus on Multidisciplinary Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus (2018 Edition)Shuqun Cheng, Minshan Chen, Jianqiang Cai, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|November 24, 2016
Simultaneous hepatic resection benefits patients with synchronous colorectal cancer liver metastasesYuan Li, Xinyu Bi, Jianjun Zhao, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|May 3, 2014
[Clinical characteristics and prognosis of three rare and poor-prognostic subtypes of primary liver carcinoma]Zhiyu Li, Zhen Huang, Xinyu Bi, et al.
Translational Cancer Research|February 4, 2022
A nomogram to predict prognosis after surgery for young patients with hepatocellular carcinomaXingchen Li, Xinyu Bi, Jianjun Zhao, et al.
Frontiers in Oncology|April 19, 2024
FOLFOXIRI plus cetuximab as conversion therapy for unresectable RAS/BRAF wild-type left-sided colorectal cancer with liver-limited metastases: a prospective dual-center pilot studyWenwei Yang, Dong Chen, Yaru Niu, et al.
Oncotargets and Therapy|February 27, 2014
Recent advances in the ARID family: focusing on roles in human cancerChen Lin, Wei Song, Xinyu Bi, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|September 23, 2014
[Correlation of carcinoembryonic antigen with prognosis of hepatocellular carcinoma after hepatectomy]Jianjun Zhao, Tao Yan, Xinyu Bi, et al.
Frontiers in Oncology|December 6, 2021
Lenvatinib Plus Immune Checkpoint Inhibitors Improve Survival in Advanced Hepatocellular Carcinoma: A Retrospective StudyXiaozhun Huang, Lin Xu, Teng Ma, et al.
Hepatobiliary Surgery and Nutrition|October 21, 2022
Neoadjuvant radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus: a systematic reviewZhewen Wei, Jianjun Zhao, Xinyu Bi, et al.
Trends in Biotechnology|March 5, 2025
CarveAdornCurate: a versatile cloud-based platform for constructing multiscale metabolic modelsYang Cheng, Wenwen Yu, Xinyu Bi, et al.
Pageof 14

Showing results (31-40 of 132) with videos related to

Sort By:
Pageof 14
Liver Cancer|February 20, 2020
Chinese Expert Consensus on Multidisciplinary Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus (2018 Edition)Shuqun Cheng, Minshan Chen, Jianqiang Cai, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|November 24, 2016
Simultaneous hepatic resection benefits patients with synchronous colorectal cancer liver metastasesYuan Li, Xinyu Bi, Jianjun Zhao, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|May 3, 2014
[Clinical characteristics and prognosis of three rare and poor-prognostic subtypes of primary liver carcinoma]Zhiyu Li, Zhen Huang, Xinyu Bi, et al.
Translational Cancer Research|February 4, 2022
A nomogram to predict prognosis after surgery for young patients with hepatocellular carcinomaXingchen Li, Xinyu Bi, Jianjun Zhao, et al.
Frontiers in Oncology|April 19, 2024
FOLFOXIRI plus cetuximab as conversion therapy for unresectable RAS/BRAF wild-type left-sided colorectal cancer with liver-limited metastases: a prospective dual-center pilot studyWenwei Yang, Dong Chen, Yaru Niu, et al.
Oncotargets and Therapy|February 27, 2014
Recent advances in the ARID family: focusing on roles in human cancerChen Lin, Wei Song, Xinyu Bi, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|September 23, 2014
[Correlation of carcinoembryonic antigen with prognosis of hepatocellular carcinoma after hepatectomy]Jianjun Zhao, Tao Yan, Xinyu Bi, et al.
Frontiers in Oncology|December 6, 2021
Lenvatinib Plus Immune Checkpoint Inhibitors Improve Survival in Advanced Hepatocellular Carcinoma: A Retrospective StudyXiaozhun Huang, Lin Xu, Teng Ma, et al.
Hepatobiliary Surgery and Nutrition|October 21, 2022
Neoadjuvant radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus: a systematic reviewZhewen Wei, Jianjun Zhao, Xinyu Bi, et al.
Trends in Biotechnology|March 5, 2025
CarveAdornCurate: a versatile cloud-based platform for constructing multiscale metabolic modelsYang Cheng, Wenwen Yu, Xinyu Bi, et al.
Pageof 14